MyoKardia (MYOK) Reports Q2 Loss of $0.41/Share

MyoKardia (NASDAQ: MYOK) reported Q2 EPS of ($0.41), versus ($0.37) reported last year. Revenue for the quarter came in at $5.63 million, versus $3.55 million reported last year.

For earnings history and earnings-related data on MyoKardia (MYOK) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Target raises full-year sales forecast amid ongoing turnaround drive
• Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance